Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
NFL
U.S.
2024 Election
Local
World
Science
Technology
AI
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
FDA may take steps to ban red food dye
Red food dye could soon be banned as FDA reviews petition: ‘Scary stuff’
The U.S. Food and Drug Administration is considering banning an artificial food coloring called Red No. 3 due to potential health risks, including a link to cancer.
Will the FDA ban red dye 3? Controversial food additive used in candy, drinks under scrutiny
While the FDA has claimed that red 3, like other additives the agency has approved, can be safe to consume, advocates have long called for its ban amid concerns that the food dye is linked to cancer and behavioral problems in children.
FDA to consider banning red food dye — an ingredient not allowed in skin products yet ‘a kid can eat it’
The U.S. Food and Drug Administration (FDA) may enact a total ban on red food dye, the artificial coloring that’s not allowed in skin products but “a kid can eat it.” On December 5, the FDA gathered for a health committee meeting with the U.S. Senate to discuss a petition regarding Red No. 3, otherwise referred to as Erythrosine.
FDA Recalls Duloxetine Antidepressant for Cancer Risk
Corn Salsa Recall as FDA Sets Risk Level
The Food and Drug Administration ( FDA) has set the risk level for a corn salsa at a "class 2 recall," stating that 192 jars of the salsa have been recalled due to having a pH of 4.7.
FDA Recalls Duloxetine Antidepressant for Cancer Risk: What to Know
Over 8 million U.S. adults take antidepressants to treat mild to moderate depression, anxiety and, in some cases, chronic pain. A recent Food and Drug Administration (FDA) recall of a commonly prescribed antidepressant,
Antidepressant Duloxetine recalled in the US over cancer risk concerns
Rising Pharmaceuticals has voluntarily recalled over 233,000 bottles of Duloxetine in the US due to potential contamination with N-nitroso-duloxetine, a probable carcinogen. The FDA classified the recall as Class II,
6m
Microbot Medical® Announces FDA Submission for the Commercialization of the LIBERTY® Endovascular Robotic System
Submission Follows the Successful Completion of the Pivotal Human Clinical TrialFDA 510(k) Clearance Anticipated During the Second ...
2d
on MSN
FDA may outlaw food dyes ‘within weeks’: Bombshell move would affect candy, soda and cakes, revolutionize American diets
The Food and Drug Administration will decide on a ban of certain food dyes after receiving a petition to review their safety.
1d
on MSN
Spice Recall Update as FDA Sets Most Serious Risk level
Con Yeager Spice Company is voluntarily recalling its Hickory Jerky Kits after it was discovered they contained a different ...
Opinion
5h
Opinion
Regular regulation: Agencies like the EPA and FDA do more than the public sees
This week, the Environmental Protection Agency moved to largely ban the use of trichloroethylene and tetrachloroethylene, ...
3d
FDA must disclose more COVID-19 vaccine records, US judge rules
A federal judge has ordered the U.S. Food and Drug Administration to publicly disclose more information underpinning its ...
4d
on MSN
Senators grill FDA on ultra-processed food, key part of RFK Jr.’s agenda
Senator Bernie Sanders and Kennedy have a common goal: tackling chronic disease by cracking down on ultra-processed food.
18h
FDA adds 2 more toxic products to large supplement recall: What you need to know
The Food and Drug Administration has expanded its recall of supplements that contain a dangerous toxin that can be fatal.
BioSpace
1d
FDA Action Alert: Ionis, Lexicon, AstraZeneca/Daiichi Sankyo and More
Ionis Pharmaceuticals is advancing the investigational RNA-targeted therapy olezarsen for the treatment of familial ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Related topics
Trump
Food and Drug Administration
recall
red dye
Elon Musk
Feedback